Artificial pancreas design using subcutaneous insulin infusion without pre-meal feed-forward boluses often induces an over-response leading to hypoglycemia due to the increase of blood insulin concentration sustained in time. The objective of this work was to create an algorithm for controlling the function of insulin pumps in closed-loop systems to improve blood glucose management in type 1 diabetic patients by mimicking the pulsatile behaviour of the pancreas.
Methods:
A controller tuned in a pulsatile way promotes damped oscillations of blood insulin concentration injected through an insulin pump. We tested it in a simulated environment, using nine ‘in silica’ subjects. The control algorithm is founded on feedback linearization where through a change of variables, the nonlinear system turns into an equivalent linear system, suitable for implementing through a PID controller. We compared the results obtained ‘in silica’ with the volume injected by an insulin pump controlled by this algorithm.
Results:
The use of this algorithm resulted in a pulsatile control of postprandial blood glucose concentration, avoiding hypoglycaemic episodes. The results obtained ‘in silica’ were replicated in a real pump ‘in vitro’.
Conclusions:
With this proposed linear system, an appropriate control input can be designed. The controller works with a damped pulsatile pattern making the insulin infusion from the pump and blood insulin concentration pulsatile. This operational would improve the performance of an artificial pancreas.
NathanDEdicD.The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview. Diabetes Care2014; 37: 9–16.
2.
SrinivasanALeeJDassauE, et al. Novel insulin delivery profiles for mixed meals for sensor-augmented pump and closed-loop artificial pancreas therapy for type 1 diabetes mellitus. J Diabetes Sci Technol2014; 8: 957–968.
3.
KlonoffD.Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care2005; 28: 1231–1239.
4.
HeinemannLFlemingGPetrieJ, et al. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs. Diabetes Care2015; 38: 716–722.
5.
PettusJPriceDAEdelmanSV.How patients with type 1 diabetes translate continuous glucose monitoring data into diabetes management decisions. Endocr Pract2015; 21: 613–620.
6.
BallyLThabitHHovorkaR.Closed-loop for type 1 diabetes. An introduction and appraisal for the generalist. BMC Med2017; 15: 14–19.
7.
BlauwHKeith-HynesPKoopsR, et al. A review of safety and design requirements of the artificial pancreas. Ann Biomed Eng2016; 44: 3158–3172.
8.
O’KeeffeDMarakaSBasuA, et al. Cybersecurity in artificial pancreas experiments. Diabetes Technol Ther2015; 17: 664–666.
9.
DeVriesJHSnoekFKostenseP, et al. The artificial pancreas-ready for prime time?Lancet Diabetes Endocrinol2017; 5: 238–239.
10.
BenbowSJWalshAGillG.Brittle diabetes in the elderly. J R Soc Med2001; 94: 578–580.
11.
BergmanRNPhillipsLSCobelliC.Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest1981; 68: 1456–1467.
12.
HeinemannLXII. Variability of insulin absorption and insulin action. Diabetes Technol Ther2002; 4: 673–682.
13.
BergmanRNXIII. Minimal model: perspective from 2005. Horm Res Paediatr2005; 64: 8–15.
14.
BergmanRNIderYZBowdenCR, et al. Quantitative estimation of insulin sensitivity. Am J Physiol1979; 236: E667–E677.
15.
BequetteBW.Analysis of algorithms for intensive care unit blood glucose control. J Diabetes Sci Technol2007; 1: 813–824.
16.
BretonMManCCobelliC.In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol2009; 3: 44–55.
17.
ColmegnaPHSánchez-PeñaRSGondhalekarR, et al. Reducing glucose variability due to meals and postprandial exercise in T1DM using switched LPV control: in silico studies. J Diabetes Sci Technol2016; 10: 744–753.
18.
TurksoyKSamadiSFengJ, et al. Meal-detection in patients with type 1 diabetes: a new module for the multivariable adaptive artificial pancreas control system. IEEE J Biomed Health Inform2016; 20: 47–54.
19.
IsidoriA.Nonlinear control systems. London: Springer Verlag, 1995.
20.
D’AttellisCE.Introducción a los sistemas no lineales de control y sus aplicaciones. Argentina, BA: Asociación Argentina de Control Automático, 1992.
21.
MarchettiGBaroloMJovanovicL, et al. An improved PID switching control strategy for type 1 diabetes. IEEE Trans Biomed Eng2008; 55: 857–865.
LynchSBequetteB. Model predictive control of blood glucose in type I diabetics using subcutaneous glucose measurements. In: Proceedings of the 2002 American control conference (IEEE Cat. No.CH37301), Anchorage, AK, 8–10 May 2002, vol. 5, pp.4039–4043. New York: IEEE.
24.
NeatpisarnvanitCBostonJR.Estimation of plasma insulin from plasma glucose. IEEE Trans Biomed Eng2002; 49(11): 1253–1259.
25.
CohenGHCoonGA.Theoretical consideration of retarded control. Trans ASME1953; 75: 827–834.
26.
AngKHChongGLiY.PID control system analysis, design, and technology. IEEE Trans Control Syst Technol2005; 13: 559–576.
27.
SharmaRMohantySBasuA. Tuning of digital PID controller for blood glucose level of diabetic patient. In: IEEE international conference on recent trends in electronics, information & communication technology (RTEICT), Bangalore, India, May 20-21, 2016, pp.332–336. New York: IEEE.
28.
Sánchez-PeñaRColmegnaPGarelliF, et al. Artificial pancreas: clinical study in Latin America without premeal insulin boluses. Diabetes Sci Technol2018; 12: 914–925.
29.
RorsmanPAshcroftF.Pancreatic cell electrical activity and insulin secretion: of mice and men. Physiol Rev2018; 98: 117–214.
30.
PørksenNMunnSSteersJ, et al. Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting. Am J Physiol1995; 269: E478–E488.
31.
SchmitzOBrockBHollingdalM, et al. High-frequency insulin pulsatility and type 2 diabetes: from physiology and pathophysiology to clinical pharmacology. Diabetes Metab2002; 28(6 Suppl): 4S14–4S20.
32.
LeeBSongTLeeK, et al. Phase modulation of insulin pulses enhances glucose regulation and enables inter-islet synchronization. PLoS One2017; 12(2): e0172901.
33.
ZhangXDaouATruongT, et al. Synchronization of mouse islets of Langerhans by glucose waveforms. Am J Physiol Endocrinol Metab2011; 301: E742–E747.
34.
SantosRRosarioLNadalA, et al. Wide spread synchronous [Ca2+]i oscillations due to bursting electrical activity in single pancreatic islets. Pflugers Arch1991; 418: 417–422.
35.
MatthewsEO’ConnorM.Dynamic oscillations in the membrane potential of pancreatic islet cells. J Exp Biol1979; 81: 75–91.
36.
BergstenPHellmanB.Glucose-induced amplitude regulation of pulsatile insulin secretion from individual pancreatic islets. Diabetes1993; 42: 670–674.
37.
MeierJVeldhuisJButlerP.Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes2005; 54: 1649–1656.
38.
SatinLButlerPHaJ, et al. Pulsatile insulin secretion, impaired glucose tolerance and type 2 diabetes. Mol Aspects Med2015; 42: 61–77.
39.
O’RahllySTurnerRCMatthewsDR.Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med1988; 318: 1225–1230.
40.
MahmudNHIsseNHDaudNA, et al. Evaluation of PD/PID controller for insulin control on blood glucose regulation in a type-I diabetes. In: AIP conference proceedings, 2017, Solo, IndonesiaAugust 3-5, 2016, vol. 1788, no. 1, p.030072. AIP Publishing LLC.
41.
PaolissoGGambatoSTorellaR, et al. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes. J Clin Endocrinol Metab1988; 66: 1220–1226.
